ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial
The differential effect of treatment by smoking was not explained by TP53 mutations or other molecular alterations examined. Molecular mechanisms of acquired resistance were detected, but no novel molecular alterations were identified in the combination arm.
Authors
- Stephen P. Finn (ORCID: https://orcid.org/0000-0002-8628-5814)
- Rolf A. Stahel (ORCID: https://orcid.org/0000-0003-4815-8870)
- Ernest Nadal (ORCID: https://orcid.org/0000-0002-9674-5554)
- Chong Ming Yeo (ORCID: https://orcid.org/0000-0003-0353-1686)
- Ji‐Youn Han (ORCID: https://orcid.org/0000-0001-5033-0006)
- Ross Andrew Soo (ORCID: https://orcid.org/0000-0002-3053-3997)
- Roswitha Kammler (ORCID: https://orcid.org/0000-0002-5572-7894)
- Patrick Vagenknecht
- Solange Peters (ORCID: https://orcid.org/0000-0002-0412-7143)
- Byoung Chul Cho (ORCID: https://orcid.org/0000-0002-5562-270X)
- Christian Britschgi (ORCID: https://orcid.org/0000-0001-8831-1564)
- Javier de Castro (ORCID: https://orcid.org/0000-0002-3622-6306)
- Georgia Dimopoulou
- Urania Dafni (ORCID: https://orcid.org/0000-0003-4367-4497)
- Mariano Provencio (ORCID: https://orcid.org/0000-0001-6315-7919)
- Enric Carcereny (ORCID: https://orcid.org/0000-0001-5235-5602)
- M.Á. Sala González
- Linda Coate
Institutions
- Yonsei University (KR)
- National and Kapodistrian University of Athens (GR)
- University of Zurich (CH)
- Trinity College Dublin (IE)
- Hospital Universitario La Paz (ES)
- Centre Hospitalier Universitaire Vaudois (CH)
- Tan Tock Seng Hospital (SG)
- University Hospital Limerick (IE)
- National Cancer Center (US)
- Hospital de Basurto (ES)
- Kantonsspital Winterthur (CH)
- University Hospital of Zurich (CH)
- National University Cancer Institute, Singapore (SG)
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
- Institut Català d'Oncologia (ES)
- National Cancer Center (KR)
- Frontier Science Foundation-Hellas (GR)
- St. James's Hospital (IE)
- International Breast Cancer Study Group (CH)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1158/1078-0432.ccr-24-0932
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.42